Novyra Pharmachem Ltd
BBSE:NOVYRA8.50
INR
-0.21
(-2.41%)
ISIN
INE856E01019
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- Surat India
- IPO Date
- Jul 10, 2017
- Website
- novyrapharmachemltd.com
- Similar Companies
- Business
- Novyra Pharmachem Ltd is an India-based diversified commercial enterprise engaged in the supply, trading, and distribution of pharmaceutical chemicals, the cultivation and processing of tea, and real estate development. The company structures its commercial activities across three principal business segments: Pharmaceuticals and Chemicals, Tea Plantation and Processing, and Real Estate Operations. The company provides a comprehensive range of products and services, comprising pharmaceutical raw materials, fine chemicals, active pharmaceutical ingredients (APIs), bulk chemical intermediates, and specialty compounds; agro-commodities including bulk black tea, green tea, CTC and orthodox processed teas, specialty herbal infusions, and plantation management and tea garden leasing services; and commercial real estate development, asset management, and property leasing solutions. Novyra Pharmachem Ltd caters to an extensive customer base consisting of pharmaceutical manufacturers, chemical formulators, wholesale commodity distributors, food and beverage retailers, and commercial tenants across regional and domestic markets in India, maintaining operational presence primarily in the states of Gujarat and West Bengal. Founded on August 9, 1987, the company is headquartered in Surat, Gujarat, India, and trades publicly on the Bombay Stock Exchange under the ticker NOVYRA. In recent corporate developments, the organization completed a significant strategic transformation in January 2026, changing its corporate name from Bansisons Tea Industries Limited to Novyra Pharmachem Ltd to reflect its strategic diversification from legacy agricultural operations into the pharmaceutical and specialty chemicals sectors. As part of this reorganization, the company amended its charter documents to formally incorporate pharmaceutical chemical trading into its core business objectives, relocated its registered corporate office from Siliguri, West Bengal, to Surat, Gujarat, to enhance supply chain proximity to key chemical manufacturing hubs, and restructured its operational and board governance frameworks to support new commercial distribution lines.